You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
HYPERTENSION: Captopril is indicated for the treatment of hypertension Consideration should be given to the risk of neutropenia/ agranulocytosis when using captopril (see PRECAUTIONS). Captopril is effective alone and in combination with other antihypertensive agents, especially thiazide-type diuretics. The blood pressure lowering effects of captopril and thiazides are approximately additive. MYOCARDIAL INFARCTION - Captopril is indicated to improve survival following myocardial infarction in clinically stable patients with left ventricular dysfunction, manifested as an ejection fraction less than or equal to 40% and to reduce the incidence of overt heart failure, and subsequent hospitalisation for congestive heart failure in these patients. The efficacy data for the use of captopril following myocardial infarction are strongest for initiation of therapy beyond 3 days post-infarct. HEART FAILURE - Captopril is indicated for the treatment of heart failure. In symptomatic patients it is recommended that captopril be administered together with a diuretic. DIABETIC NEPHROPATHY - Captopril is indicated for the treatment of diabetic nephropathy (proteinuria > 500mg/day) in patients with Type 1 insulin-dependent diabetes mellitus. In these patients captopril reduces the progression of renal disease and reduces associated clinical sequelae (dialysis, renal transplantation and death).
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
HYPERTENSION: Captopril is indicated for the treatment of hypertension. Consideration should be given to the risk of neutropenia/ agranulocytosis when using captopril (see PRECAUTIONS). Captopril is effective alone and in combination with other antihypertensive agents, especially thiazide-type diuretics. The blood pressure lowering effects of captopril and thiazides are approximately additive. MYOCARDIAL INFARCTION - Captopril is indicated to improve survival following myocardial infarction in clinically stable patients with left ventricular dysfunction, manifested as an ejection fraction less than or equal to 40% and to reduce the incidence of overt heart failure, and subsequent hospitalisation for congestive heart failure in these patients. The efficacy data for the use of captopril following myocardial infarction are strongest for initiation of therapy beyond 3 days post-infarct. HEART FAILURE - Captopril is indicated for the treatment of heart failure. In symptomatic patients it is recommended that captopril be administered together with a diuretic. DIABETIC NEPHROPATHY - Captopril is indicated for the treatment of diabetic nephropathy (proteinuria > 500mg/day) in patients with Type 1 insulin-dependent diabetes mellitus. In these patients captopril reduces the progression of renal disease and reduces associated clinical sequelae (dialysis, renal transplantation and death).
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
HYPERTENSION: Captopril is indicated for the treatment of hypertension Consideration should be given to the risk of neutoipenia/ agranulocytosis when using captopril (see PRECAUTIONS). Captopril is effective alone and in combination with other antihypertensive agents, especially thiazide-type diuretics. The blood pressure lowering effects of captopril and thiazides are approximately additive. MYOCARDIAL INFARCTION - Captopril is indicated to improve survival following myocardial infarction in clinically stable patients with left ventricular dysfunction, manifested as an ejection fraction less than or equal to 40% and to reduce the incidence of overt heart failure, and subsequent hospitalisation for congestive heart failure in these patients. The efficacy data for the use of captopril following myocardial infarction are strongest for initiation of therapy beyond 3 days post-infarct. HEART FAILURE - Captopril is indicated for the treatment of heart failure. In symptomatic patients it is recommended that captopril be administered together with a diuretic. DIABETIC NEPHROPATHY - Captopril is indicated for the treatment of diabetic nephropathy (proteinuria > 500mg/day) in patients with Type 1 insulin-dependent diabetes mellitus. In these patients captopril reduces the progression of renal disease and reduces associated clinical sequelae (dialysis, renal transplantation and death).
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
Government Accredited with over 140 information partners
We are a government-funded service, providing quality, approved health information and advice
Healthdirect Australia acknowledges the Traditional Owners of Country throughout Australia and their continuing
connection to land, sea and community. We pay our respects to the Traditional Owners and to Elders both past and
present.
